ctrl K

Watchlist Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.42

-0.17 (-2.24%)

At close: Jun 16, 2025, 3:59 PM

7.37

-0.67%

After-hours: Jun 16, 2025, 07:10 PM EDT

Entrada Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	210.78M	129.01M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	99.88M	1.9M	1.12M	326K	104K
Gross Profit	207.01M	29.13M	-1.9M	-1.12M	-326K	-104K
Operating Income	47.01M	-3.16M	-97.25M	-51.13M	-26.67M	-11.82M
Interest Income	19.47M	15.22M	2.63M	n/a	144K	451K
Pretax Income	66.48M	12.06M	-94.62M	-51.16M	-26.52M	-5.1M
Net Income	65.63M	-6.68M	-87.46M	-50.07M	-26.38M	-4.65M
Selling & General & Admin	38.47M	32.29M	30.64M	15.2M	5.57M	3.61M
Research & Development	125.31M	99.88M	66.61M	35.93M	21.1M	8.22M
Other Expenses	n/a	n/a	n/a	n/a	n/a	6.27M
Operating Expenses	163.77M	132.18M	97.25M	51.13M	26.67M	11.82M
Interest Expense	n/a	n/a	2.63M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	163.77M	132.18M	97.25M	51.13M	26.67M	11.82M
Income Tax Expense	859K	18.74M	-7.16M	-1.09M	-144K	-451K
Shares Outstanding (Basic)	37.31M	33.05M	31.29M	31.22M	31.25M	31.25M
Shares Outstanding (Diluted)	39M	33.05M	31.29M	31.22M	31.25M	31.25M
EPS (Basic)	1.76	-0.2	-2.79	-1.6	-0.84	-0.15
EPS (Diluted)	1.68	-0.2	-2.79	-1.6	-0.84	-0.15
EBITDA	47.01M	-321K	-95.35M	-50.01M	-26.34M	-11.72M
EBIT	47.01M	-3.16M	-97.25M	-51.16M	-26.67M	-11.82M
Depreciation & Amortization	n/a	2.84M	1.9M	1.12M	326K	104K